Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study.

Bettonte, Sara; Berton, Mattia; Stader, Felix; Battegay, Manuel; Marzolini, Catia

Bettonte, Sara; Berton, Mattia; Stader, Felix; Battegay, Manuel; Marzolini, Catia.

Afiliación

Bettonte S; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital Basel, Basel, Switzerland.
Berton M; Faculty of Medicine, University of Basel, Basel, Switzerland.
Stader F; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital Basel, Basel, Switzerland.
Battegay M; Faculty of Medicine, University of Basel, Basel, Switzerland.
Marzolini C; PBPK Research and Development, Certara UK Limited, Sheffield, UK.

Clin Infect Dis ; 76(7): 1225-1236, 2023 04 03.

Article en En | MEDLINE | ID: mdl-36377436

Asunto(s)

Fármacos Anti-VIH; Infecciones por VIH; Humanos; Femenino; Masculino; Rilpivirina; Rifampin; Infecciones por VIH/tratamiento farmacológico; Antirretrovirales/uso terapéutico; Interacciones Farmacológicas; Fármacos Anti-VIH/uso terapéutico

Palabras clave

PBPK modeling; drug-drug interaction; inducer; long-acting cabotegravir; long-acting rilpivirine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH Tipo de estudio: Guideline / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google